Spark Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-15,100
| Closed | -$125K | – | 58 |
|
|
2020
Q2 | $125K | Sell |
15,100
-161,893
| -91% | -$1.34M | 0.46% | 43 |
|
|
2020
Q1 | $1.36M | Sell |
176,993
-26,607
| -13% | -$204K | 0.72% | 33 |
|
|
2019
Q4 | $1.69M | Sell |
203,600
-133,564
| -40% | -$1.11M | 0.2% | 154 |
|
|
2019
Q3 | $2.49M | Sell |
337,164
-95,817
| -22% | -$707K | 0.32% | 102 |
|
|
2019
Q2 | $4.86M | Hold |
432,981
| – | – | 0.34% | 94 |
|
|
2019
Q1 | $4.65M | Buy |
432,981
+222,381
| +106% | +$2.39M | 0.22% | 130 |
|
|
2018
Q4 | $3.18M | Sell |
210,600
-13,900
| -6% | -$210K | 0.22% | 136 |
|
|
2018
Q3 | $4.15M | Sell |
224,500
-22,600
| -9% | -$418K | 0.24% | 135 |
|
|
2018
Q2 | $5.65M | Sell |
247,100
-43,600
| -15% | -$997K | 0.33% | 90 |
|
|
2018
Q1 | $8.27M | Buy |
290,700
+53,800
| +23% | +$1.53M | 0.53% | 44 |
|
|
2017
Q4 | $5M | Hold |
236,900
| – | – | 0.27% | 111 |
|
|
2017
Q3 | $4.3M | Hold |
236,900
| – | – | 0.23% | 154 |
|
|
2017
Q2 | $3.67M | Buy |
236,900
+135,200
| +133% | +$2.1M | 0.23% | 149 |
|
|
2017
Q1 | $1.76M | Buy |
101,700
+35,000
| +52% | +$604K | 0.11% | 273 |
|
|
2016
Q4 | $733K | Buy |
66,700
+42,796
| +179% | +$470K | 0.06% | 400 |
|
|
2016
Q3 | $374K | Buy |
+23,904
| New | +$374K | 0.03% | 542 |
|
|
2016
Q2 | – | Sell |
-30,900
| Closed | -$398K | – | 795 |
|
|
2016
Q1 | $398K | Buy |
+30,900
| New | +$398K | 0.04% | 495 |
|